Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 6/20 | 0.52 |
| ▸ | SRC | P12931 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | XBP1 | P17861 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.45 |
| ▸ | MLYCD | O95822 | 1/20 | 0.45 |
| ▸ | CES2 | O00748 | 4/20 | 0.44 |
| ▸ | TSHR | P16473 | 3/20 | 0.44 |
| ▸ | DAO | P14920 | 1/20 | 0.44 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | PGR | P06401 | 1/20 | 0.41 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2187223 | 0.86 | MDM2 (0.47) | CES1SRCMAPTLMNAXBP1 | |
| SCHEMBL28567881 | 0.81 | CES1 (0.52) | CES1SRCMAPTLMNAXBP1 | |
| SCHEMBL27384600 | 0.80 | CES1 (0.50) | CES1SRCMAPTLMNAXBP1 | |
| SCHEMBL6699073 | 0.80 | CES1 (0.50) | CES1SRCMAPTLMNAXBP1 | |
| SCHEMBL8463346 | 0.80 | CES1 (0.50) | CES1SRCMAPTLMNAXBP1 | |
| SCHEMBL507732 | 0.80 | CES1 (0.50) | CES1SRCMAPTLMNAXBP1 | |
| SCHEMBL13647200 | 0.78 | CES1 (0.59) | CES1SRCMAPTLMNAXBP1 | |
| SCHEMBL10493250 | 0.77 | CYP1A2 (0.48) | CES1SRCMAPTLMNAXBP1 | |
| SCHEMBL9005042 | 0.75 | CES1 (0.55) | CES1SRCMAPTLMNAXBP1 | |
| SCHEMBL3349927 | 0.75 | CYP1A2 (0.52) | CES1SRCMAPTLMNAXBP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114699328-A | Photoprotective compositions | 欧莱雅 | 2022-07-05 | — | — | CN | claimed |
| CN-101316577-B | Personal care compositions containing silicone resins with enhanced properties and methods of making and using the same | MOMENTIVE PERFORMANCE MAT INC | 2015-07-15 | — | — | CN | claimed |
| CN-101031277-B | Use of photostabilized cosmetic or dermatological composition | CIBA SPEC CHEM CORP | 2012-12-05 | — | — | CN | claimed |
| CN-101505717-A | Photostable cosmetic compositions | UNILEVER NV (NL) | 2009-08-12 | — | — | CN | claimed |
| CN-101316577-A | Personal care compositions containing silicone resins with enhanced properties and methods of making and using the same | MOMENTIVE PERFORMANCE MAT INC (US) | 2008-12-03 | — | — | CN | claimed |
| CN-101219093-A | Cosmetic composition containing a dibenzoylmethane derivative and a siloxanic benzoate arylalkyl amide derivative | OREAL (FR) | 2008-07-16 | — | — | CN | claimed |
| WO-2008067928-A1 | UV ABSORBING COMPOSITIONS CONTAINING A PYRROLYLTRIAZINE | ISDIN S.A. (ES) | 2008-06-12 | — | — | WO | claimed |
| CN-101095648-A | Dibenzoylmethane sunscreens photostabilized with arylalkyl amide or ester compounds | OREAL (FR) | 2008-01-02 | — | — | CN | claimed |
| CN-1798538-A | Photostable organic sunscreen composition | MERCK PATENT GMBH (DE) | 2006-07-05 | — | — | CN | claimed |
| EP-1635777-A1 | PHOTOSTABLE ORGANIC SUNSCREEN COMPOSITION | MERCK PATENT GmbH (DE) | 2006-03-22 | — | — | EP | claimed |
| CN-1425366-A | Anti-sun light cosmetic composition based on sun screening agent synergic mixture and its use | OREAL (FR) | 2003-06-25 | — | — | CN | claimed |
| CN-1424018-A | San screener containing 1,3,5-triazine derivative, dibenzoylmethane derivative and amino substitued 2-hydroxy-benzene ketone derivative | OREAL (FR) | 2003-06-18 | — | — | CN | claimed |
| CN-1092514-C | Photostable screening composition comprising dibenzoylmethane derivative and polysaccharide alkyl ether, and uses thereof | OREAL (FR) | 2002-10-16 | — | — | CN | claimed |
| CN-1352544-A | Material containing organic UV-A sunscreen agent and method for shifting maximum absorption wavelength | OREAL (FR) | 2002-06-05 | — | — | CN | claimed |
| CN-1327379-A | Method for improving UV radiation stability of photosensitive sunscreen filters | OREAL (FR) | 2001-12-19 | — | — | CN | claimed |
| US-20010026789-A1 | Photostabilized sunscreen compositions comprising dibenzoylmethane compounds and benzylidenecamphor-substituted silanes/organosiloxanes | RICHARD HERVE (FR) | 2001-10-04 | — | — | US | claimed |
| CN-1307468-A | Sunscreen composition | PROCTER & GAMBLE (US) | 2001-08-08 | — | — | CN | claimed |
| CN-1214239-A | Light-screening agents | HOFFMANN LA ROCHE (CH) | 1999-04-21 | — | — | CN | claimed |
| CN-1207290-A | Cosmetic light-screening composition | HOFFMANN LA ROCHE (CH) | 1999-02-10 | — | — | CN | claimed |
| CN-1173324-A | Photostable screening composition comprising dibenzoylmethane derivative and polysaccharide alkyl ether, and uses thereof | OREAL (FR) | 1998-02-18 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010026789-A1 | Photostabilized sunscreen compositions comprising dibenzoylmethane compounds and benzylidenecamphor-substituted silanes/organosiloxanes | DSG1, DDT, DSC1 | CES1 2324/4885SRC 464/4885MAPT 289/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.